Skip to content

Can dental treatment protect us from heart disease?

Does periodontal treatment prevent platelet activation in patients with periodontitis? A controlled therapeutic trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17035727
Enrollment
100
Registered
2018-01-12
Start date
2015-11-01
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Oral Health Periodontitis

Interventions

Eligible patients undergo baseline anamnesis of periodontal disease, microbiological assessment (PCR, 11 putative periodontal pathogens) and blood testing and full medical and dental histories were co

Sponsors

Anniversary Fund of the Austrian National Bank
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Understanding of the study requirements 2. At least one interproximal site with a probing depth = 5 mm and a loss of attachment at = 2 interproximal sites = 5 mm 3. Ages 18 and older

Exclusion criteria

Exclusion criteria: 1. Systemic diseases including diabetes mellitus 2. Chronic renal failure or liver cirrhosis 3. Systemic antibiotic treatment in the preceding 3 months 4. Periodontal treatment within the last 4 months 5. Pregnancy or breast feeding 6. Medication which affects platelets

Design outcomes

Primary

MeasureTime frame
Platelet P-selectin surface expression is measured using whole blood from patients and laboratory analysis via flow cytometry before and immediately after treatment and 3 months after.

Secondary

MeasureTime frame
Platelet aggregation is measured using whole blood from patients and laboratory analysis via light transmission aggregometry before and immediately after treatment and 3 months after.

Countries

Austria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026